InterventionsHuman trial
Bezisterim Treatment Is Associated with Changes in DNA Promoter Methylation Linked to Epigenetic Aging, Metabolic Risk, and Neurodegenerative Pathways
ADA Scientific Sessions 2026 Abstract
The paper
READING C, YAN J, AHLEM C et al.
ADA Scientific Sessions 2026 Abstract · 5 Jun 2026
Presented at ADA Scientific Sessions 2026 · Poster 1795-P
